Kintara Therapeutics, Inc. /
TuHURA Biosciences, Inc.
Kintara Therapeutics and TuHURA Biosciences complete merger transaction
What happened
Kintara Therapeutics, Inc. completed its merger with TuHURA Biosciences, Inc., a Delaware corporation, on Oct. 18, 2024. TuHURA survived the merger and became Kintara’s direct, wholly-owned subsidiary. Kintara then changed its name to TuHURA Biosciences, Inc.
TuHURA is a clinical stage immuno-oncology company developing personalized cancer vaccine candidates and bi-functional antibody drug conjugates.
The source
Everything on this page comes from the source below.
Kintara Therapeutics and TuHURA Biosciences complete merger transaction
This document is the source for the companies, stage and people on this page.
Source-verifiedTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Closed
The source this page is built from.
Source-verifiedPublished by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly